New Epstein document release includes multiple Trump mentions, but little revelatory news. Here’s how Tuesday unfolded.

It was the latest batch in a slow drip that began Friday, the deadline that Congress had set for the release of all the files ...
MyChesCo on MSN

FDA fast track puts Palvella’s rare skin drug on a faster regulatory path

WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) said the U.S. Food and Drug Administration has granted Fast Track designation to QTORIN™ rapamycin for the treatment of angiokeratomas, a rare ...

Best BPC-157 Oral Supplements: ProHealth's Triple-Tested Formula Examined as Peptide Quality Verification Becomes Consumer Priority Heading Into 2026

Third-Party Lab Testing, Bioavailability Questions, and Regulatory Status ExaminedCARPINTERIA, Dec. 23, 2025 (GLOBE NEWSWIRE) ...